Answers - Finance

Life insurance is a popular policy investment sold by various insurance companies. In order

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

to safeguard personal interests and those of the family, a large number of people opt to pur

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

chase a life insurance. In due course of time, if a policyholder is diagnosed with a termina

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

l illness, the insurance company is legally bound to recompense the person. In case of an in

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

urable ailment, policyholders need to spend on expensive medical treatment, to ensure comfor

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

t for the remaining years of their life. These medical expenses can be huge and policyholder

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

s may choose to cash in, on their life insurance. This is termed as a 'viatical' settlement

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

nd a number of investors are willing to pay for them.

In this agreement, a terminally ill p

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

olicyholder sells his life insurance at a discounted rate. This settlement provides ready ca

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

sh and is a legal exchange. People opt for such settlements as they eliminate the risk of ha

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ding over personal assets for cash. In such an exchange, policyholders need to name the inv

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

estors as beneficiaries in case of death. They cash in on such investments, when the person

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

dies. The investors are only concerned with their profitability or return on investments and

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

this depends upon the life expectancy of the policyholder.

The rate of return is unpredict

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ble and in case of longer life expectancy, returns are lower. A number of people choose cash

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

for life insurance settlements. This is logical, as risking other assets for cash jeopardiz

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

es the situation of the surviving family members. The need for cash is optimum when diagnose

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

with a terminal illness. Money is needed for treatment that can help slow or partially cont

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

rol the spread of the disease. Investors examine medical records, diagnosis and prognosis to

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

confirm the seriousness of the illness before providing cash for life insurance settlements

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/118255/answers-Cash-For-Life-Insurance-Settlements.html">Cash For Life Insurance Settlements</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/118255/answers-Cash-For-Life-Insurance-Settlements.html]Cash For Life Insurance Settlements[/url]

If you are anything like me, you spend a lot of time researching joint ventures and going through the chore of analysing all the joint venture proposals you get on a daily basis in your inbox. I've ...

This article includes a sample letter for credit repair. Letters like these are sent to a credit bureau or credit reporting agency to report inaccuracies on your credit report.

Need a loan for your business? Don’t have sufficient collateral? You have a respite in the form of unsecured business loans.

Tags

Links

Answers - Cash For Life Insurance Settlements

Related Articles: